A Novel Coronavirus Emerging in World — Key Questions for Developing Countries and Under Developed Countries

Novel coronavirus, assigned as 2019-nCoV, rose in Wuhan, China, toward the finish of 2019. As of January 24, 2020, in any event 830 cases had been analyzed in nine nations: China, Thailand, Japan, South Korea, Singapore, Vietnam, Taiwan, Nepal, and the United States. Twenty-six fatalities happened, for the most part in patients who had genuine hidden illness.1 Although numerous subtleties of the rise of this infection —, for example, its birthplace and its capacity to spread among people — stay obscure, an expanding number of cases seem to have come about because of human-to-human transmission. Given the serious intense respiratory disorder coronavirus (SARS-CoV) episode in 2002 and the Middle East respiratory disorder coronavirus (MERS-CoV) flare-up in 2012,2 2019-nCoV is the third coronavirus to develop in the human populace in the previous two decades — a rise that has put worldwide general wellbeing establishments on high alarm.